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Pruritus is the major symptom of ocular allergy but currently available treatments are often ineffective.
Previous studies demonstrated that subpopulations of primary sensory neurons express Fc receptors and
may contribute to antigen-specific pain. We investigated the role of neuronal Fc-epsilon Receptor I
(FceRI) in allergic ocular pruritus. Ovalbumin (OVA) was used as allergen together with alum adjuvant
(OVA + alum) to produce a mouse model of ocular allergy with a significant elevation in the serum levels
of both antigen-specific IgE and IgG. Mice sensitized by OVA without alum only induced elevation of
serum IgG but not IgE. Scratching behavior toward the eyes with the hindlimb was used as an indicator
of ocular itch. Topical OVA challenging to the eye dose-dependently induced scratching toward the eye in
the OVA + alum sensitized mice, but not those sensitized by OVA only. The antigen-induced scratching
was largely abolished by topical application of the blocking antibody to FceRIa, but was only partially
alleviated by pretreatment of mast cell stabilizer or histamine I receptor antagonist. The expression of
FceRI was detected in subpopulations of trigeminal ganglion (TG) neurons including those expressing
pruriceptive markers and innervating the conjunctiva in the naïve mice. Moreover, FceRI was found
significantly upregulated in small-sized TG neurons in the OVA + alum sensitized mice. In acutely disso-
ciated TG neurons, IgE-immune complex (IC), but not the antibody or antigen alone, induced intracellular
calcium increase. The neuronal responses to IgE-IC could be specifically blocked by pre-application of a
siRNA for FceRIa. Our results indicate that FceRI expressed on peripheral nociceptive neurons in the TG
may be directly activated by IgE-IC and contribute to allergic ocular pruritus. This study may suggest a
novel mechanism for the development of pathological itch in allergic diseases.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under theCCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Itch is an unpleasant sensation that elicits the desire or reflex to
scratch (Ikoma et al., 2006; Dhand and Aminoff, 2014). The sensa-
tion of itch shares a number of similar characteristics with pain
and is likely transmitted by certain unmyelinated C fibers in theperipheral nerve that was classified as nociceptor or, more specif-
ically, pruriceptors (Steinhoff et al., 2006; LaMotte et al., 2014).
Antigen-specific immune diseases such as atopic and allergic der-
matitis are often accompanied with pathological itch as well as
pain (Galli and Tsai, 2012; Greaves and Wall, 1996). Patients with
allergic disorders usually have an elevated level of antigen-specific
immunoglobulin (Ig), especially IgE in the serum (Galli and Tsai,
2012). IgE may bind with specific allergen forming immune com-
plex (IC). IgE-IC can induce itch via three steps: IgE-IC activate
immune cells via Fc epsilon receptor (FceR); activated immune
cells release pro-inflammatory mediators and pruritogens (such
as histamine, tryptase, cytokines); pruritogens induce itch by acti-
vating peripheral sensory neurons (Turner and Kinet, 1999; Rivera,
2002; Stone et al., 2010). It has been well known that IgE may
activate certain immune cells such as mast cells upon binding withallergy.
2 F. Liu et al. / Brain, Behavior, and Immunity xxx (2016) xxx–xxxallergen and trigger a series of immune responses which can
produce itch and/or pain. However, current therapeutics targeting
histamine receptors or mast cells do not always effectively relieve
the discomfort of itch or stop the destructive behavior which can
produce tissue damage in certain pathological conditions such as
allergic conjunctivitis or dermatitis.
FceR type I (FceRI) is the high-affinity activating receptor that
binds to the Fc portion of IgE. FceRI has been defined structurally
as a trimeric form (ac2) or a tetrameric form (abc2) (Turner and
Kinet, 1999; Conner and Saini, 2005). The a-chain containing two
immunoglobulin-type domains is the IgE binding chain. The b-
and c-chains contain conserved immunoreceptor tyrosine-based
activation motifs (ITAMs) (Turner and Kinet, 1999; Rivera, 2002;
Stone et al., 2010; Conner and Saini, 2005; Okayama et al., 2014).
FceRI typically expresses on immune cells (such as mast cell in skin
and mucosa, or basophils in blood vessels). As suggested in a pre-
vious report (Andoh and Kuraishi, 2004; van der Kleij et al., 2010)
and in our pilot studies (Liu et al., 2015, 2014), FceRI may express
in dissociated mouse dorsal root ganglia (DRG) neurons but the
function of neuronal FceRI was unknown. It was not clear whether
the peripheral sensory neurons could be directly activated by
IgE-IC.
We hypothesize that a subpopulation of peripheral nociceptive
(including pruriceptive) neurons that express FceRI can be directly
activated by IgE-IC inducing itch and/or pain. Furthermore, the
expression of neuronal FceRI and responses to IgE-IC may be mod-
ulated in allergic diseases therefore contributing to the exagger-
ated pruritus in such conditions. We tested these hypotheses in
ovalbumin allergic mouse model of ocular itch. Our findings
revealed a novel neural mechanism for the sensation of itch, and
might suggest potential therapeutic strategies for the treatment
of pruritus related to allergic diseases.2. Materials and methods
2.1. Animals
Adult male C57BL/6 mice (20–25 g; 6–8 wk, National Institutes
for Food and Drug Control, Beijing, China) were used in this study.
The Mrgprd (Zylka et al., 2005) and Mrgpra3 (Han et al., 2013)
transgenic mice were generous provided by Dr. Xinzhong Dong
(Johns Hopkins University School of Medicine). Mice were housed
in temperature (23 ± 3 C) and 12 h light/dark cycle controlled
rooms with standard rodent chow and water available. The exper-
imental protocols were approved by the Institutional Animal Care
and Use Committee in Chinese Academy of Medical Sciences, Insti-
tute of Basic Medical Sciences. Animals were randomly assigned to
treatment or control groups.2.2. Reagents
Capsaicin, BSA, BAM8-22, Cromolyn sodium, HEPES, ovalbumin
(OVA), poly-D-lysine, laminin, terfenadine were purchased from
Sigma-Aldrich (St. Louis, MO, USA). Armenian hamster anti-
FceRIa antibody, Armenian Hamster monoclonal IgG Isotype con-
trol, and rabbit anti-FceRIc were from Abcam (Cambridge, UK).
Rabbit anti-FceRIa, mouse anti-FceRIb, and goat anti-FceRIc were
from Santa Cruz Biotechnology (Dallas, Texas, USA). Guinea pig
anti-PGP9.5 was from LifeSpan Biosciences (Seattle, WA, USA).
Mouse anti-b-actin was from ZSJQ (Beijing, China). Alexa Fluor
488-conjugated donkey anti-rabbit, Alexa Fluor 488-conjugated
donkey anti-mouse, Alexa Fluor 488-conjugated donkey anti-
goat, and Alexa Fluor 594-conjugated donkey anti-guinea pig were
from Jackson ImmunoResearch Laboratories (West Grove, PA, USA).
Protease inhibitors and chemiluminescent reagents (eECL Kit) werePlease cite this article in press as: Liu, F., et al. Neuronal Fc-epsilon receptor I c
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Liberase TM were from Roche Diagnostics (Indianapolis, IN, USA).
DMEM and F12 medium, FBS, Fura 2-acetoxy-methyl ester and
Imject Alum, TriZol Reagent and LipofectamineRNAi MAX Reagent
were from Thermo Fisher Scientific (Waltham, MA, USA). Papain
was from Worthington Biochemical (Lakewood, NJ, USA). RT
Master Mix and SYBR premix Ex TaqTM were from TAKARA
(Dalian, China); VECTASHIELD Mounting Medium with DAPI was
from Vector Lab (Burlingame, CA, USA).
IgE-IC was prepared by using the OVA as antigen and the
affinity-purified mouse anti-OVA IgE (Acris Antibodies, Inc) as anti-
body. The storage buffer of all the antibodies (containing sodium
azide as preservative) was exchanged to HEPES buffer using ZebaTM
spin desalting columns (Thermo Scientific) before application to
avoid the possible toxic or non-specific effects of sodium azide.
IgE-IC were formed by incubating 1 lg/ml antigen and antibody
at the ratio of 1:1 for 1 h at 25 C, and then diluting to the concen-
trations of 0.01, 0.1, 0.3, and 1 lg/ml. In control experiments, indi-
vidual components of IC (i.e. mouse anti-OVA IgE, OVA) were
applied.
2.3. Sensitization and challenging of mice
A mouse model of ovalbumin sensitization induced ocular itch
was produced with the following procedures: on day 0, day 7
and day 14, i.p. injection of 100 lg OVA plus 100 ll Imject Alum
dissolved in 400 ll of normal saline. On days 21, 10 ll of OVA
(0.001–5% in normal saline) were applied topically to both eyes
to induce ocular allergy (Groneberg et al., 2003).
2.4. Behavioral assessment for ocular itch and pain
Behavioral assessment for ocular itch and pain in the mice were
preformed following the procedures as described in previous pub-
lications (Shimada and LaMotte, 2008; Huang et al., 2016). Briefly,
mice were placed in an acrylic box (13  9  40 cm) in a sound-
proof room without persons for 3 consecutive days before and
1 h on the day of recording to allow acclimation. They were
returned to the same box immediately after drug administration,
and were videotaped from the top of box with a high-resolution
digital camera (SONY HANDYCAMHDR-PJ580E, Japan) for 1 h. Four
mirrors were placed on the sides of the box for a better observation
of the mouse behavior. The numbers of bout of scratching the trea-
ted eye with its hindpaw or wiping with the ipsilateral forelimb
were counted during video playback.
2.5. Measurement of serum total and special IgG and IgE
The total IgG or IgE in the mouse serum were assessed using the
mouse IgG or IgE ELISA kit (eBioscience), respectively. Briefly,
Corning Costar 9018 ELISA plate was coated overnight at 4 C with
capture antibody. Coated wells were blocked with Blocking Buffer
at room temperature. Samples were diluted at 10,000-fold for IgG
or 25-fold for IgE. Total IgG was detected using HRP-conjugated
anti-mouse IgG monoclonal antibody; total IgE was detected using
biotin-conjugated anti-mouse IgE and Streptavidin-HRP mono-
clonal antibody as a second-step reagent, according to the manu-
facturer’s instructions. Similarly, the OVA-specific IgG1 or IgE
were measured using a Mouse OVA IgG1 or IgE ELISA kit (Cayman,
Maine, USA), respectively.
2.6. Cell dissociation and culture
TG neurons were dissociated and cultured from adult C57BL/6
mice. Briefly, TGs of both sides were harvested from the skull base
of decapitated mice after quick removal of brain, and transferredontributes to antigen-evoked pruritus in a murine model of ocular allergy.
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mincing as previously reported (Qu et al., 2011). The TGs were then
digested with Liberase TM for 20 min and for another 20 min with
Liberase TL and papain in CSS containing 0.5 mM EDTA at 37 C.
After enzymatic digestion, the cells were dissociated by gentle trit-
uration with a fire-polished Pasteur pipette in culture medium
containing 0.5 mg/ml bovine serum albumin and 0.5 mg/ml trypsin
inhibitor and placed on poly-D-lysine/laminin-coated 12-mm
diameter circular glass coverslips (BioCoat, BD Biosciences). The
culture medium contained equal amounts of DMEM and F12 with
10% FBS. The cells were maintained at 37 C in a humidified atmo-
sphere of 95% air and 5% CO2 and were used within 24 h.
2.7. Immunohistochemistry
Immunohistochemistry for dissociated TG neurons: TG cells
cultured for 18–24 h were post-fixed in cold 80% acetone for
0.5 h under 4 C. After washing with PBS, the coverslips were incu-
bated with 3% BSA for 1 h followed by overnight incubation at 4 C
with one of the primary antibodies (rabbit anti-FceRIa, 1:150,
Santa Cruz Biotechnology; mouse anti-FceRIb, 1:150, Santa Cruz
Biotechnology; goat anti-FceRIc, 1:100, Santa Cruz Biotechnology;
or guinea pig anti-PGP9.5, 1:100), and then with the proper
secondary antibodies (Alexa Fluor 488-conjugated donkey anti-
rabbit, 1:400; Alexa Fluor 488-conjugated donkey anti-mouse,
1:400; Alexa Fluor 488-conjugated donkey anti-goat, 1:400; or
Alexa Fluor 594-conjugated donkey anti-guinea pig, 1:400, respec-
tively) for 1 h at 25 C before washing and mounting.
Immunohistochemistry for TG cryosections: TGswere harvested
from adult mice transcardially perfused with PBS followed by 4%
paraformaldehyde, post-fixed in the same fixative for 4 h, and then
cryoprotected in 20% sucrose overnight. The tissue was frozen and
sectioned at 10 lm thick on a cryostat. Tissue sections were perme-
abilized with 0.2% Triton X-100 in PBS for 15 min, then incubated
with 10% normal horse serum for 1 h, followed by overnight incuba-
tion at 4 C with one of the primary antibodies (rabbit anti-FceRIa,
1:150; mouse anti-FceRIb, 1:150; or goat anti-FceRIc, 1:100), and
then with the proper secondary antibodies (Alexa Fluor 488-
conjugated donkey anti-rabbit, 1:400; Alexa Fluor 488-conjugated
donkey anti-mouse, 1:500; or Alexa Fluor 488-conjugated donkey
anti-goat, 1:500, respectively) for 1 h. The slides were then washed
in PBS and cover-slipped with VECTASHIELD Mounting Medium
with DAPI.
The cells were visualized and the images captured using a laser
confocal microscopic imaging system (Olympus FV1000 and
FluoView software). At least 12 fields of view (200X) from 3
sections on each ganglion were examined. Only neuronal somata
(diameter > 10 lm, and with PGP9.5 in dissociated neurons) were
included in the data analysis to avoid possible contamination from
non-neuronal cells expressing FceR. More than 100 neuronal
somata with nucleus profiles for each condition were counted
and the percentiles of immunopositive neurons were reported.
Neurons were classified according to the cross-sectional diameter
of soma as small- (< 25 lm), medium- (25–35 lm) and large-
sized (> 35 lm).
2.8. Western blotting
Freshly harvested mouse TG tissue or dissociated TG neurons
were homogenized in modified RIPA buffer with protease inhibi-
tors. The homogenates (25 lg of protein) were separated by SDS-
PAGE and transferred to a PVDF membrane. After incubation in
5% BSA solution for 1 h, the membranes were followed by over-
night incubation at 4 C with the one of the primary antibodies:
hamster anti-FceRIa (1:1000), mouse anti-FceRIb (1:100, Santa
Cruz Biotechnology), rabbit anti-FceRIc (1:300) and mouse anti-Please cite this article in press as: Liu, F., et al. Neuronal Fc-epsilon receptor I c
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the corresponding HRP-conjugated anti-IgG antibody (goat
anti-hamster IgG, 1:1500; goat anti-mouse IgG, 1:4000 and goat
anti-rabbit IgG, 1:4000). Bands were determined using eECL Kit.2.9. Quantitative RT-PCR
Total RNA was extracted from TG neurons with TriZol Reagent.
Then cDNA was synthesized from 500 ng by using the prime script
RT Master Mix according to the manufacturer’s protocol. Approxi-
mately 100 ng RNA-equivalent cDNA template was used per well,
and qRT-PCR was performed using a CFX96TM Real-Time PCR
Detection System (Bio-Rad) with SYBR premix Ex TaqTM. The
sequences of primers for FceRIa, FceRIb, FceRIc and b-Actin control
are presented in Table 1.2.10. Small interfering RNA transfection
TG neurons were transfected with either a Stealth small inter-
fering RNA (siRNA) or a Stealth RNAi negative control (Invitrogen)
using the LipofectamineRNAi MAX Reagent according to the man-
ufacturer’s instructions. The target sequences of the Stealth siRNAs
were 50GCUAUGGGAACAAUCACCUUCAAAU30 and 50AUUUGAAGG
UGAUUGUUCCCAUAGC30 for FceRIa; and StealthTM RNAi Negative
Control Duplexes (Medium GC) for the scrambled control of
FceRIa. After 6 h treatment with siRNA, the medium was changed
with DMEM containing 10% FCS, and the cells were incubated for
24 h. The neurons without the addition of siRNA to the transfection
reagents were used as an empty vector negative control.2.11. Intracellular calcium imaging
Intracellular calcium imaging was performed as described
before (Qu et al., 2011, 2012). Cultured mouse TG neurons were
incubated with Fura 2-acetoxy-methyl ester (2 lM) in the dark
for 45 min at 37 C. After loading with calcium sensitive dye, TG
neurons were washed twice in HEPES buffer to remove extracellu-
lar dye, and placed in a recording chamber continuously perfused
with HEPES buffer at a flow rate of 1.5 ml/min at room tempera-
ture. Images were recorded using an upright NIKON ECLIPSE Ti
microscope equipped with a ratiometric imaging system (Nikon
NIS-Elements AR 4.00.00, Japan). The ratio of 340 nm/380 nm fluo-
rescence intensity (R340/380) within a certain region of interest after
background subtraction was used as a relative measure of intracel-
lular calcium concentration ([Ca2+]i). Calibration with external
standards (Calcium Calibration Buffer Kit, Invitrogen) showed that
R340/380 increased linearly with [Ca2+]i up to about 1 lM and
R340/380 of 0.7–1.25 corresponded to basal [Ca2+]i of 90–180 nM.
Therefore, neurons (6 25 lm) with R340/380 at the range of
0.7–1.25 were included in this study.
All reagents were dissolved in HEPES buffer and applied locally
to the neuronal cell bodies through a micropipette (with a tip
diameter of 100 lm) and an 8-channel pressure-controlled drug
application system (VC3-8PP, ALA Scientific). The interval between
drug applications was at least 1 min. The viability of the dissoci-
ated TG neurons was confirmed by the increase in [Ca2+]i produced
by a 5-s application of HEPES containing 50 mM K+ at the end of
each experiment. The proportion of TG neurons responsive to IC
was calculated as the number of IC-responsive neurons divided
by all the viable neurons tested. Neurons were considered cap-
saicin sensitive (CAP+) if a 10-s application of 1 lM capsaicin
evoked an increase in R340/380 that was equal or greater than 20%
above baseline. Capsaicin sensitive and insensitive neurons were
analyzed separately.ontributes to antigen-evoked pruritus in a murine model of ocular allergy.
Table 1
List of primer sequences designed for qPCR.
Target gene Primer sequence 50-30 Product length (bp) GenBank No.
FceRIa FORWARD GCTATGGGAACAATCACCTTCA 101 NM_010184.2
REVERSE GGCACTCACAATGACCAAATGT
FceRIb FORWARD GGGCAGAGGACCAGAACAT 214 NM_013516.2
REVERSE CCCTTGGACACATGGAGAAC
FceRIc FORWARD TCAAGATCCAGGTCCGAAAG 215 NM_010185.4
REVERSE AGCCAACCTTCAAAGCACAG
b-Actin FORWARD GTCCCTCACCCTCCCAAAAG 266 NM_007393
REVERSE GCTGCCTCAACACCTCAACCC
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Data values are presented as means with standard errors
(mean ± SEM). Statistical analyses were performed using the SPSS
software (version 17.0). A Student0s t test was used to evaluate
the statistical significance of a difference between mean responses
of two groups. Statistical comparisons of differences among three
or more groups were made with a one-way analysis of variance
(ANOVA) followed by Scheffe0s post hoc test. Chi-square tests were
used to compare between two or more incidence of events. The cri-
terion for statistical significance was a value of P < 0.05.3. Results
3.1. Scratching with the hindlimb as a indicator for ocular itch in the
mice
It has been reported that scratching with the hindlimb is a
behavioral indicator of pruritic stimuli to the cheek of mice, and
wiping with forelimb is an indicator of pain (Shimada and
LaMotte, 2008). We first tested that such a behavior model also
applies to the eyes in naïve mice. When capsaicin solution (5 ll,
5 lM freshly prepared in 0.1% Tween 20) was dropped to the
eye, a stimulation that produces ocular irritation/pain in human,
the mice demonstrated a significant increase of wiping with the
forelimb toward the eye, but not a significant increase of scratching
with the hindlimb as compared to the vehicle (Fig. 1A–B). In con-
trast, when a pruritogen Bam8-22 (5 ll, 10 lM in saline) (Han
et al., 2013; Liu et al., 2009) was dropped to the eye, the mice
showed significant increase of scratching but not wiping toward
the eye (Fig. 1A–B). Therefore we concluded that scratching with
the hindlimb is an indicator for ocular itch while wiping with hin-
dlimb is an indicator for ocular pain in the mice.
3.2. A mouse model of antigen-specific ocular pruritus
We produced a mouse model of ocular pruritus via topical
application of a specific antigen to the eyes of antigen-sensitized
mice. Immunization with either OVA alone or OVA and alum adju-
vant (OVA + alum) significantly increased the serum concentration
of total IgG and allergen-specific IgG1, although the IgG and IgG1
concentrations were much less in the OVA-alum group (Fig. 1C-
D). However, a significantly increased serum concentration of total
IgE and allergen-specific IgE are found only in the mice sensitized
with OVA + alum, but not in those sensitized with OVA alone
(Fig. 1E–F).
Pruritic and painful responses to OVA allergen were examined
in the mice according to the assay established above in 3.1. Topical
application of allergen (OVA 0.1–5%, 5 ll dropped to the eye) dose-
dependently induced a pruritic response, i.e. hind-paw scratching
of the treated eye in OVA + alum sensitized mice but not in the
naïve or OVA sensitized mice (Fig. 1G). There was no significantPlease cite this article in press as: Liu, F., et al. Neuronal Fc-epsilon receptor I c
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these groups (Fig. 1G). Among all doses tested, topical application
of 1% OVA evoked the highest scratching responses (Fig. 1G–H),
which started almost immediately after challenge, peaked during
the first 10 min, and decreased gradually in 60 min (Fig. 1I). Com-
pared to the naïve or OVA sensitized groups, the number of
scratching bouts/hr was significantly higher in the OVA + alum
sensitized mice immediately or at 24 h after OVA challenging,
but not at 12 h after challenging (Fig. 1J).
In order to examine the role of mast cell degranulation, his-
tamine release and FceRI in the allergen-evoked ocular pruritus,
we pre-administrated a mast cell stabilizer cromolyn sodium (6%
in NS, 5 ll eye drop t.i.d. for 3 days), an antihistamine terfenadine
(30 mg/kg i.p., 1 h before challenge), or a blocking antibody of
FceRI (Armenian Hamster monoclonal anti-Fc epsilon RI antibody,
1 lg/ll in NS, 5uL eye drop t.i.d. for 3 days) before challenging with
allergen in the naïve and OVA and alum sensitized mice. All three
treatments significantly reduced the number of scratching bouts
(Fig. 1K–M). The blocking antibody of FceRI demonstrated the
strongest effect by almost completely abolished the scratching
evoked by OVA, as compared to the effects of mast cell stabilizer
or antihistamine (Fig. 1K–M).3.3. Expression of neuronal FceRI in the TG
FceRI was known to express on proinflammatory cells (such as
in mast cells or basophils) in tetrameric form (abc2) (Turner and
Kinet, 1999; Rivera, 2002; Okayama et al., 2014; Matsuda et al.,
2008). Using double immunofluorescent staining, we found that
the FceRIa, b and c were expressed on the surface of dissociated
TG neurons that were immunopositive for neuron specific marker
protein PGP9.5 (Fig. 2A-I). We also found that the conjunctival
mucosa was innervated by FceRIa positive neurons, as indicated
by DiI tracer injected into the conjunctiva (Supplementary
Fig. S1A–C). In two transgenic mice lines with GFP expressed in
tentative pruriceptive neurons (MrgprA3+ or MrgprD+) (Zylka
et al., 2005; Han et al., 2013), we found that 23.1% FceRIa
immunopositive neurons co-express MrgprA3, and 27.3% FceRIa
immunopositive neurons co-express MrgprD (Supplementary
Fig. S1D–I). Immunofluorescent staining using the polyclonal and
monoclonal antibodies produced similar results on cryosections
of TG (Supplementary Fig. S2). These findings suggested that func-
tional FceRI might express in pruriceptive TG neurons innervating
the conjunctiva.
Next, qPCR and western blotting was used to detect the expres-
sion of all three subunits of FceRI (a, b and c) in the TG of naïve and
sensitized mice. The results showed that mRNA and protein levels
of FceRIa in TG were significantly increased in OVA + alum sensi-
tized mice. Only the mRNA, but not protein level of FceRIa were
found significantly increased in OVA sensitized mice (Fig. 3A-B).
Immunofluorescent staining indicated that the increased FceRIa
was only detected in small-sized TG neurons (somalontributes to antigen-evoked pruritus in a murine model of ocular allergy.
Fig. 1. OVA challenging induced ocular itch in the OVA + alum sensitized mice. A, Topical application of capsaicin (5 ll, 5 lM) induced wiping with the forelimb toward the
eye. B, Topical application of a pruritogen Bam8-22 (5 ll, 10 lM in saline) induced mainly scratching with the hindlimb toward the eye. Vehicle1 and Vehicle2 are vehicles for
capsaicin and Bam8-22, respectively *P < 0.05 vs. vehicle, t test, n = 6 per group (A and B). C–D, Injection of OVA alone or OVA with the adjuvant (OVA + alum) increased the
levels of both total IgG (C) and OVA-specific IgG (D) in the serum. E–F, Injection of OVA + alum, but not OVA alone, increased the levels of both total IgE (E) and OVA-specific
IgE (F) in the serum. *P < 0.01 vs. naïve, #P < 0.05 vs. OVA, one-way ANOVA, n = 8 per group (C–F). G, Topical application of OVA dose-dependently increased the scratching
(sc.) but not wiping (wp.) behaviors toward the challenged eye in the OVA + alum sensitized (OVA + alum) mice. *P < 0.05 vs. naïve, one-way ANOVA, n = 8 per group. H,
Cumulative scratch bouts within 1 h after challenging with vehicle (saline, NS) or allergen (1% OVA) in the naïve, OVA sensitized and OVA + alum sensitized mice. I, Changes in
the number of scratching bouts for each 10-min bin within the first hour after OVA challenging in the naïve, OVA sensitized or OVA + alum sensitized group. J, OVA allergen
induced an acute (1 h) and chronic (24 h) pruritic response (scratching) in OVA + alum sensitized mice. *P < 0.05 vs. naïve or OVA, one-way ANOVA, n = 8 per group (H and J).
K, Effects of pretreatment of mast cell stabilizer cromolyn sodium (6% eye drop) or vehicle (saline) in Naïve and OVA + alum sensitized mice after allergen challenging. L,
Effects of pretreatment with terfenadine (30 mg/kg i.p.) or vehicle (saline) in Naïve and OVA + alum sensitized mice after allergen challenging. M, Effects of pretreatment with
hamster anti-FceRIa antibody (10 lg, 1 lg/ll eye drop) or control antibody (Armenian Hamster monoclonal IgG Isotype control) in Naïve and OVA + alum sensitized mice
after allergen challenging. *P < 0.05 vs. naïve; #P < 0.05 vs. vehicle or control antibody, two-way ANOVA, n = 6 per group (I, J, K).
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Fig. 2. Expression of FceRI in mouse TG neurons. A–I, FceRIa (A), b (D), and c (G)-immunoreactivity was found co-localized with the neuronal marker PGP 9.5 (B, E, H) in
dissociated TG neurons. C, F and I showed the merged images. Arrows indicated FceRI-immunopositive neurons. Scale bar (in I): 25 lm.
6 F. Liu et al. / Brain, Behavior, and Immunity xxx (2016) xxx–xxxdiameter < 25 lm), but not in large- or medium-sized neurons in
the TG (Fig. 3C–F). The mRNA and protein levels of FceRIb were
found significantly increased in the OVA + alum sensitized mice
(Fig. 4A–B). Immunofluorescent staining showed the increased
immunoreactivity of FceRIb in the TG neurons (Fig. 4C–D). For
FceRIc, significantly increased mRNA level was found in both the
OVA and OVA + alum sensitized mice (Fig. 4F), but the western
blotting (Fig. 4G) and immunofluorescent staining (Fig. 4H–J) did
not reveal much difference between the sensitized and naïve mice.
The low-affinity IgE receptor (CD23 or FceRII) was significantly
decreased in the TG of sensitized mice as revealed by immunoflu-
orescent staining and western blotting (Supplementary Fig. S3).
3.4. IgE-IC induced [Ca2+]i increase in the TG neurons via FceRI
We further examined whether neuronal FceRI could be directly
activated by IgE-IC using calcium imaging. Different concentra-
tions (0.01–1 lg/ml by antibody) of IgE-IC formed by mouse
anti-OVA IgE (antibody) and OVA (antigen) were administrated
to dissociated TG neurons via topical application. Antigen (OVA)
or antibody (IgE) alone did not evoke any change in the [Ca2+]i in
TG neurons (Fig. 5A–B). Application of IgE-IC dose-dependently
evoked [Ca2+]i increase in TG neurons from both naïve and OVA +
alum sensitized mice (Fig. 5A–C). The [Ca2+]i returned slowly to
baseline at least 3 min after washout of IC in most neurons tested.
Interestingly, the IgE-IC (1 lg/ml) evoked calcium responses werePlease cite this article in press as: Liu, F., et al. Neuronal Fc-epsilon receptor I c
Brain Behav. Immun. (2016), http://dx.doi.org/10.1016/j.bbi.2016.11.017only observed in small-sized TG neurons (12.0% or 11/92), but
not in large- (0/20) or medium-sized neurons (0/30) (p < 0.05,
Chi-square test).
The changes in [Ca2+]i as measured by R(340/380) were not signif-
icantly different between naïve and OVA + alum mice across all the
doses applied (Fig. 5C). Neither was the percentage of IgE-IC
responsive neurons significantly different between naïve and
OVA + alum sensitized mice for any of the doses tested (0.01–
1 lg/ml), although the percentages are always higher in the sensi-
tized group (Fig. 5D). The percentages of TG neurons responding to
IgE-IC were: naïve: 4.3% (5/117) for 0.01 lg/ml, 7.1% (3/42) for
0.1 lg/ml, 9.0% (8/89) for 0.3 lg/ml, and 12.0% (11/92) for 1 lg/
ml; OVA + alum sensitized: 4.3% (3/70) for 0.01 lg/ml, 9.5%
(8/84) for 0.1 lg/ml, 13.3% (13/98) for 0.3 lg/ml, and 14.5%
(19/131) for 1 lg/ml.
IgE-IC induced calcium responses were observed in both
capsaicin-sensitive (15.2%, 10/66) and capsaicin-insensitive (9.0%,
7/112) TG neurons from naïve mice, and also in both capsaicin-
sensitive (21.8%, 17/78) and capsaicin-insensitive (3.6%, 15/140)
TG neurons from OVA + alum sensitized mice. On the other hand,
the percentage of capsaicin-sensitivity in IC-responsive TG neurons
was similar between naïve (58.8%, 10/17) and OVA + alum mice
(53.1%, 17/32).
In order to determine the role of neuronal FceRI in the IgE-IC
induced [Ca2+]i increase, FceRIa (the IgE binding chain) was
knocked down with a specific siRNA in dissociated TG neurons.ontributes to antigen-evoked pruritus in a murine model of ocular allergy.
Fig. 3. Upregulation of FceRIa subunit in the TG of sensitized mice. A, qPCR for the mRNA levels of FceRIa subunit in TG of naïve, OVA, or OVA + alum sensitized mice. B,
Western blot showing the protein levels of FceRIa subunit in TG. Inset: example gel image for western blot. C, The percentage of FceRIa-immunopositive neuronal somata in
different size groups in the TG. D–F, Typical images for the immunofluorescence staining of FceRIa in the naïve (D), OVA (E) or OVA + alum sensitized mice (F). Arrows
indicated FceRIa-immunopositive neurons (green-fluorescence) with nuclear profiles (blue-fluorescence). *P < 0.05 vs. naïve, One-way ANOVA in A–B (n = 3 for each group) or
v2 test in C (n > 100 neurons total for each group). Scale bar (in F): 25 lm. (For interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
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confirmed by Quantitative RT-PCR (Fig. 6A), western blotting
(Fig. 6B) and immunofluorescent staining (Fig. 6C). Both the
amount of IgE-IC evoked increase in R(340/380) and the percentage
of responsive neurons were significantly reduced in FceRIa
siRNA-transfected TG neurons (n = 92) as compared to the negative
control vector-transfected TG neurons (n = 109, transfected
StealthTM RNAi) (Fig. 6D–F). These findings indicate that IgE-IC
induces [Ca2+]i increase via neuronal FceRI in the TG.4. Discussion
Pruritus is the major symptoms of allergic conjunctivitis
(Rosario and Bielory, 2011; Berdy and Hedqvist, 2000; Bielory,
2008), the most common form of ocular allergy that affects up to
40% population of the United States and 35% in Europe (Asher
et al., 2006; Beasley, 1998; Petricek et al., 2006). Although treat-
ments targeting inflammatory mediators or immune cells such as
antihistamine, mast cell stabilizer and steroid have been widely
used to treat allergic pruritus, the results are often partially effec-
tive and unsatisfying (Berdy and Hedqvist, 2000; Bielory, 2008;
Fonacier et al., 2010; Steinhoff et al., 2012; Duffull and Begg,
1992; Buddenkotte et al., 2010; Simons and Simons, 2011;
Kumar, 2009). The present study showed that a mouse model of
allergic ocular pruritus elicited ocular scratching with the hind-
paw, an itch- but not pain-specific behavior. We found that topical
application of OVA antigen elicited ocular itch-related behaviors in
the OVA + alum sensitized mice with an increased serum level of
antigen-specific IgE as well as IgG, but not in the OVA alone
sensitized mice with increased serum level of IgG only. Therefore
the binding of IgE and antigen, i.e. IgE-IC was required to produce
ocular pruritus. In accord with our findings, site-specific scratching
behaviors were also reported in previous studies of allergen-
elicited ocular pruritus (Shii et al., 2009; Andoh et al., 2012). ThePlease cite this article in press as: Liu, F., et al. Neuronal Fc-epsilon receptor I c
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treatment with mast cell stabilizer or H1 histamine receptor antag-
onist, but could be almost totally abolished by the FceRI blocking
antibody. These results are concordant with previous reports that
cutaneous allergic itch in the mice could not be totally inhibited
by H1 histamine receptor antagonist and mast cell stabilizer
(Inagaki et al., 1999; Bell et al., 2004), and indicate that allergic itch
may involve factors other than inflammatory mediators and
residential immune cells. Previous studies showed that mast cell
that express the high-affinity IgE receptor FceRI can be directly
activated via allergen (antigen) with IgE (allergen-specific), and
play a key role in allergic itch. The cross-linking of IgE-IC to FceRI
on mast cells can trigger mast-cell degranulation, releasing inflam-
matory mediators such as histamine, tryptase, platelet-activating
factor, prostaglandin E2 and TNF and so on. Theses mediators can
activate the sensory terminal of peripheral nociceptive neurons
therefore inducing itch or pain (Fig. 7A). The present study
revealed that FceRI was expressed in mouse TG neurons, including
those innervating the conjunctiva and those co-expressing pruri-
ceptive neuronal markers MrgprA3 and MrgprD (Supplementary
Fig. S1). We also found that IgE-IC induced calcium changes in
certain small-sized TG neurons via neuronal FceRI. Therefore, it is
reasonable to propose that peripheral ocular endings of tentatively
pruriceptive TG neurons expressing FceRI can be directly activated
by IgE-IC and contribute to allergen-induced ocular itch (Fig. 7B).
This hypothesis was supported by our behavioral results that
pre-treatment of anti-FceRI antibody almost completely abolished
allergen-induced scratching. However, due to the presence of FceRI
in both immune cells and sensory neurons, the exact role of
neuronal FceRI in allergen-induced itch will need to be further
investigated. Moreover, antigen-induced immune responses may
evoke an acute phase (Type I hypersensitivity mainly mediated
by IgE immune complex), and a delayed phase (Type IV hypersen-
sitivity, mainly mediated by T-cells). In this study, we focus on the
acute phase of allergic ocular itch that may involve the neuronalontributes to antigen-evoked pruritus in a murine model of ocular allergy.
Fig. 4. Upregulation of FceRIb and c subunits in the TG of sensitized mice. A, qPCR for the mRNA levels of FceRIb subunit in TG of naïve, OVA, or OVA + alum sensitized mice. B,
Western blot for the protein levels of FceRIb subunit in TG. Inset: example of gel image for western blot. C–E, Immunofluorescent staining of FceRIb in TG neurons from naïve
(C), OVA sensitized (D) or OVA + alum sensitized (E) mice. Arrows indicated immunopositive neurons. F, qPCR for the mRNA levels of FceRIc subunit in TG of naïve, OVA, or
OVA + alum sensitized mice. G, Western blot for the protein levels of FceRIc subunit in TG. H–J, Immunofluorescent staining of FceRIc in TG neurons from naïve (H), OVA (I) or
OVA + alum sensitized (G) mice. Arrows indicated immunopositive neurons. *P < 0.05 vs. naïve, One-way ANOVA (in A, B, F and G, n = 3 for each group). Scale bar (in J): 25 lm.
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related behavior (Fig. 1J). The potential role of FceRI in the delayed
phase will be explored in future studies.
The present study revealed that FceRI (including a, b, and c
chains) was expressed in mouse TG neurons. It was reasonable to
hypothesis that FceRI was expressed on sensory neurons in tetra-
meric form (abc2) as previously described in immune cells
(Turner and Kinet, 1999; Rivera, 2002; Conner and Saini, 2005).
We found that the IgE binding chain FceRIa showed the most
significant upregulation after sensitization, but the underlyingPlease cite this article in press as: Liu, F., et al. Neuronal Fc-epsilon receptor I c
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ther investigation.
Recent studies showed the presence of Fc receptors including
FccR and FceR in peripheral sensory neurons in the mice and rats
(Andoh and Kuraishi, 2004; Liu et al., 2015, 2014; Qu et al., 2011,
2012; Andoh and Kuraishi, 2004; Harada et al., 2010). IgG-IC may
directly act on neuronal FccRI, evoking [Ca2+]i increase and action
potential discharges in nociceptive DRG neurons (Qu et al., 2011,
2012). In this study, we found that IgE-IC may directly act on
neuronal FceRI and evoke [Ca2+]i increase in TG neurons from bothontributes to antigen-evoked pruritus in a murine model of ocular allergy.
Fig. 6. Knockdown of FceRIa with siRNA reduced the IgE-IC evoked neuronal responses. A–C, qPCR (A), Western blotting (B) and immunofluorescent staining (C) showed
down-regulation of FceRIa in dissociated TG neurons after incubation with specific siRNA but not Negative Control siRNA (StealthTM RNAi). Scale bar: 50 lm. D–E, Typical
examples of IgE-IC evoked [Ca2+]i responses in dissociated TG neurons after transfected with Negative Control siRNA (D) or FceRIa-specific siRNA (E). F, The IgE-IC (0.3 lg/ml,
30 s) evoked [Ca2+]i response was significantly decreased in FceRIa-specific siRNA-transfected TG neurons. G, The percentage of TG neurons responsive to IgE-IC in TG
neurons transfected by FceRIa-specific or Negative Control siRNA. *P < 0.05 vs. Negative Control siRNA.
Fig. 5. IgE-IC evoke [Ca2+]i increase in dissociated TG neurons. A-B, Typical examples of calcium responses (R(340/380)) in dissociated TG neurons from naïve (A) or OVA + alum
sensitized (B)mice by topical applicationof different doses of allergenonly (OVA), antibody only (IgE), IgE-IC (IC, 0.01–1 lg/ml, 30 s), capsaicin (CAP, 1 lM,10 s), andKCl (30 mM,
5 s). C, Summary of IgE-IC evoked [Ca2+]i increase in dissociated TG neurons. D, Percentage of TG neurons responding to different doses of IgE-IC in naïve and sensitized mice.
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Fig. 7. Schematic illustration demonstrating the mechanism of IgE-IC induced itch in ocular allergy. IgE-IC may induce itch in ocular allergy via two mechanisms: A, Indirect
mechanism: Mast cells were activated and degranulated, releasing cytokines and pruritic mediator such as histamine which can activate the nerve ending of pruriceptive
neurons innervating conjunctiva and cause ocular itch. B, Direct mechanism: IgE-IC may directly bind to neuronal FceRI, activating pruriceptive neurons innervating
conjunctiva and cause ocular itch.
10 F. Liu et al. / Brain, Behavior, and Immunity xxx (2016) xxx–xxxnaïve and sensitized mice. Furthermore, knock-down of FceRIa
using siRNA in dissociated TG neurons significantly reduced the
IgE-IC induced [Ca2+]i increase, suggesting an essential role of the
neuronal FceRIa in IgE-IC induced calcium response (Fig. 6).
Although FceRI is expressed across all neuronal size categories,
the upregulation of FceRI in the TG of OVA + alum sensitized mice
was only detected in small-sized TG neurons. Accordingly, the cal-
cium responses to IgE immune complex were only observed in
small- but not in large- or medium-sized TG neurons (See Results
3.4). These results imply that small-sized TG-neuron expressing
FceRI may contribute to allergic ocular pruritus. Moreover, IgE IC
evoked calcium responses were found in both capsaicin-sensitive
and capsaicin-insensitive neurons. Although topical application of
capsaicin to the eye evoked mainly pain but not itch, previous pub-
lications indicate that most pruriceptive neurons express TRPV1
and were capsaicin-sensitive (Han et al., 2013; Ma et al., 2012).
The roles of sub-populations of IgE-IC responsive TG neurons in
itch, and the molecular mechanisms underlying the neuronal-
type specificity will be studied in the future.
Despite a upregulation of FceRI in the TG from OVA-alum sensi-
tized mice, there was no significant difference between naïve and
OVA-alum sensitized mice in the amplitude of change in [Ca2+]i
as measured by R(340/380), or the percentage of TG neurons respond-
ing to IgE-IC for all the doses tested. The lack of significant changes
between naïve and sensitized mice in calcium responses of disso-
ciated TG neurons to IgE-IC may due to insufficient sample size,
possible changes induced by culturing, or other factors. Neverthe-
less, small-sized TG sensory neurons may be directly activated by
IgE-IC in allergic conditions and contribute to ocular itch.
In summary, our results suggest that primary sensory neurons
including pruriceptors in the TG express FceRI and may be directlyPlease cite this article in press as: Liu, F., et al. Neuronal Fc-epsilon receptor I c
Brain Behav. Immun. (2016), http://dx.doi.org/10.1016/j.bbi.2016.11.017activated by IgE-IC. Neuronal FceRI, esp. FceRIa may upregulate in
sensitized mice with increased serum IgE, and may play a role in
allergic ocular pruritus. Our findings revealed a novel mechanism
of allergic ocular pruritus via direct activation of sensory neuronal
FceRI by IgE-IC. This study may suggest potential strategies for the
treatment of pruritus in ocular allergy as well as other diseases
with pathological itch.Conflict of interest statement
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